A phase II study of four-week radiation for breast cancer using hypofractionated intensity modulated radiation therapy (IMRT) with an incorporated boost
Freedman GM, Anderson P, Goldstein L, Litwin S, Li J, Watkins-Bruner D, Nicolaou N, Swaby R, Sigurdson E, Morrow M
A phase II study of four-week radiation for breast cancer using hypofractionated intensity modulated radiation therapy (IMRT) with an incorporated boost
International Journal of Radiation Oncology Biology Physics. 2006;66(3):S176-S176.